SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.17+0.7%2:06 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (13661)5/25/2000 11:15:00 AM
From: Cacaito  Read Replies (2) of 17367
 
Bluegreen, E.Coli 0157 could not be control by bpi, the mild and moderate cases do not need anything but oral or IV rehydration, peptobismol is as good (and probably better) than any antibiotic.

The main problem is Acute Hemolytic Uremic Syndrome(HUS), reports keep coming to this thread over the years, same as the West coast hamburger (Jack in the box?)and juice companies related cases,

HUS is an EXOTOXIN, not endotoxins which are the bpi target.
Most of the time bacteria never reach the bloodstream, the EXOTOXIN does.

Even peptobismol could beat a problem that xometimes bpi could not.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext